A detailed history of Mn Services Vermogensbeheer B.V. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Mn Services Vermogensbeheer B.V. holds 784,854 shares of BMY stock, worth $45.5 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares
784,854
Previous 804,254 2.41%
Holding current value
$45.5 Million
Previous $33.4 Million 21.58%
% of portfolio
0.28%
Previous 0.24%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

SELL
$39.66 - $51.75 $769,403 - $1 Million
-19,400 Reduced 2.41%
784,854 $40.6 Million
Q2 2024

Jul 25, 2024

SELL
$40.25 - $52.99 $740,600 - $975,016
-18,400 Reduced 2.24%
804,254 $33.4 Million
Q1 2024

Apr 29, 2024

SELL
$47.98 - $54.4 $8.42 Million - $9.54 Million
-175,400 Reduced 17.57%
822,654 $44.6 Million
Q4 2023

Jan 29, 2024

SELL
$48.48 - $57.85 $1.29 Million - $1.54 Million
-26,600 Reduced 2.6%
998,054 $51.2 Million
Q3 2023

Oct 25, 2023

BUY
$57.89 - $64.73 $949,396 - $1.06 Million
16,400 Added 1.63%
1,024,654 $59.5 Million
Q2 2023

Aug 09, 2023

SELL
$63.71 - $70.74 $5.08 Million - $5.65 Million
-79,800 Reduced 7.33%
1,008,254 $64.5 Million
Q1 2023

Apr 26, 2023

BUY
$65.71 - $74.53 $2.62 Million - $2.97 Million
39,900 Added 3.81%
1,088,054 $75.4 Million
Q4 2022

Feb 03, 2023

SELL
$68.48 - $81.09 $11 Million - $13 Million
-160,800 Reduced 13.3%
1,048,154 $75.4 Million
Q3 2022

Nov 01, 2022

SELL
$0.13 - $76.84 $10,348 - $6.12 Million
-79,600 Reduced 6.18%
1,208,954 $85.9 Million
Q2 2022

Aug 03, 2022

SELL
$72.62 - $79.98 $22.9 Million - $25.2 Million
-314,800 Reduced 19.63%
1,288,554 $99.2 Million
Q1 2022

May 10, 2022

SELL
$61.48 - $73.72 $6.55 Million - $7.86 Million
-106,600 Reduced 6.23%
1,603,354 $117 Million
Q4 2021

Feb 10, 2022

BUY
$53.63 - $62.52 $1.93 Million - $2.25 Million
36,000 Added 2.15%
1,709,954 $107 Million
Q3 2021

Nov 03, 2021

BUY
$59.17 - $69.31 $1.83 Million - $2.14 Million
30,900 Added 1.88%
1,673,954 $99 Million
Q2 2021

Aug 05, 2021

SELL
$61.91 - $67.42 $21.3 Million - $23.2 Million
-343,800 Reduced 17.3%
1,643,054 $92.6 Million
Q4 2020

Feb 09, 2021

BUY
$57.74 - $65.43 $1.41 Million - $1.6 Million
24,400 Added 1.24%
1,986,854 $123 Million
Q3 2020

Nov 04, 2020

BUY
$57.43 - $63.64 $2.22 Million - $2.46 Million
38,700 Added 2.01%
1,962,454 $118 Million
Q2 2020

Jul 23, 2020

SELL
$54.82 - $64.09 $3.93 Million - $4.6 Million
-71,700 Reduced 3.59%
1,923,754 $113 Million
Q1 2020

May 12, 2020

SELL
$46.4 - $67.43 $5.99 Million - $8.7 Million
-129,000 Reduced 6.07%
1,995,454 $111 Million
Q4 2019

Feb 12, 2020

BUY
$49.21 - $64.19 $33.6 Million - $43.9 Million
683,662 Added 47.45%
2,124,454 $136 Million
Q3 2019

Nov 12, 2019

BUY
$42.77 - $50.71 $25.9 Million - $30.7 Million
604,426 Added 72.27%
1,440,792 $73.1 Million
Q2 2019

Jul 25, 2019

SELL
$44.62 - $49.34 $2.91 Million - $3.22 Million
-65,200 Reduced 7.23%
836,366 $37.9 Million
Q1 2019

May 06, 2019

BUY
$45.12 - $53.8 $383,520 - $457,300
8,500 Added 0.95%
901,566 $43 Million
Q4 2018

Feb 12, 2019

BUY
$48.76 - $63.23 $30.8 Million - $39.9 Million
630,792 Added 240.51%
893,066 $40.6 Million
Q3 2018

Nov 02, 2018

BUY
$55.19 - $62.25 $270,431 - $305,025
4,900 Added 1.9%
262,274 $16.3 Million
Q1 2018

May 11, 2018

BUY
$59.92 - $68.98 $65,912 - $75,878
1,100 Added 0.43%
257,374 $16.3 Million
Q4 2017

Feb 02, 2018

SELL
$59.94 - $65.35 $923,076 - $1.01 Million
-15,400 Reduced 5.67%
256,274 $13.1 Million
Q3 2017

Nov 01, 2017

BUY
$55.23 - $63.74 $15 Million - $17.3 Million
271,674
271,674 $17.3 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Mn Services Vermogensbeheer B.V. Portfolio

Follow Mn Services Vermogensbeheer B.V. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mn Services Vermogensbeheer B.V., based on Form 13F filings with the SEC.

News

Stay updated on Mn Services Vermogensbeheer B.V. with notifications on news.